Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration

Movement Disorders

Volumn 15, Issue 2, 2000, Pages 340-343

  Frucht, Steven ^a,d   Fahn, Stanley ^a   Chin, Steven ^a   Dhawan, Vijay ^b   Eidelberg, David ^c  

^a Division of Reproductive Endocrinology   (United States)

^b Northshore University Hospital   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LEVODOPA; NEUROFILAMENT PROTEIN;

AGED; ARTICLE; ASTROCYTOSIS; AUTOPSY; CASE REPORT; CORTICOBASAL DEGENERATION; DYSKINESIA; EXTRAPYRAMIDAL SYNDROME; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; ANTIPARKINSON AGENTS; BASAL GANGLIA; BASAL GANGLIA DISEASES; CEREBRAL CORTEX; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; NEURODEGENERATIVE DISEASES; NEUROLOGIC EXAMINATION; PARKINSON DISEASE;

EID: 0034026904     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200003)15:2<340::AID-MDS1025>3.0.CO;2-O     Document Type: Article

References (10)

1. Eidelberg D, Dhawan V, Moeller JR. et al. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991;54:856-862.
2. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RSJ. Corticobasal degeneration: a unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991;114:541-556.
3. Nagasawa H, Tanji H, Nomura H, et al. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. J Neurol Sci 1996;139:210-217.
4. Watts RL, Brewer RP. Cortical-basal ganglionic degeneration: classical clinical features and natural history. Mov Disord 1996; 11:346.
5. Brown J, Lantos PL, Roques P, Fidani L, Rossor MN. Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study. J Neurol Sci 1996; 135:21-30.
6. Caselli RJ, Reiman EM, Timmann D, et al. Progressive apraxia in clinically discordant monozygotic twins. Arch Neurol 1995;52: 1004-1010.
7. Rebeiz JJ, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33.
8. Scully RE, Mark EJ, McNeely BU. Case 38-1985. N Engl J Med 1985;313:739-748.
9. Gibb WRG, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192.
10. Kompoliti K, Goetz CG, Boeve BF, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998;55:957-961.